QUALITY OF LIFE (QOL) AMONG CANCER PATIENTS WITH ORAL MUCOSITIS: A CROSS-SECTIONAL STUDY
Main Article Content
Keywords
Abstract
Oral mucositis is a common and distressing side effect experienced by cancer patients undergoing chemotherapy or radiation therapy. This cross-sectional study aimed to assess the quality of life (QOL) among cancer patients with oral mucositis. A questionnaire-based survey was conducted to collect data on the physical, emotional, and social aspects of QOL. The study sample consisted of cancer patients diagnosed with oral mucositis from various oncology centers. Descriptive statistics and inferential analysis were used to analyze the data. The study findings provide insights into the impact of oral mucositis on the QOL of cancer patients, highlighting the need for supportive care interventions to alleviate the burden of this condition.
References
1. Sonis, S. T. (2009). Oral mucositis in cancer therapy. Journal of Supportive Oncology, 7(3 Suppl), 3-8.
2. Vera-Llonch, M., Oster, G., Hagiwara, M., Sonis, S., & Sen, S. (2006). Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer, 106(2), 329-336.
3. Elting, L. S., Cooksley, C. D., Chambers, M. S., Garden, A. S., & Risk factors, R. M. (2003). Determinants of patient-reported voice and speech changes after adult allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 31(2), 115-122.
4. Dodd, M. J., Dibble, S. L., Miaskowski, C., & MacPhail, L. (2000). A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. Journal of Pain and Symptom Management, 19(5), 331-340.
5. Murphy, B. A., & Epstein, J. B. (2002). Oral mucositis: Review of pathogenesis, diagnosis, prevention, and management. Oncology-Huntington, 16(5 Suppl 7), 17-29.
6. Epstein JB, Schubert MM. Managing pain in mucositis. Seminars in Oncology Nursing. 2004; 20(1):30-37.
7. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology. 1998; 34(1):39-43.
8. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum. 2001; 28(3):465-.
9. Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and
10. Quality of life in patients with advanced cancer. Journal of Pain and Symptom Management. 2007; 33(2):156-165.
11. Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO Clinical Practice Guidelines for the Management of Mositis: Pathophysiology and Management of Mucositis Induced by Cancer Therapy. Supportive Care in Cancer. 2013; 21(9):2233-2245.
12. Mercadante S, Aielli F, Adile C, et al. Pain severity and the antecedents of patients in a palliative care setting. Supportive Care in Cancer. 2015; 23(1):15-19.
13. Elad S, Zadik Y, Garfunkel AA. Oral medicine training in North America: the tale of two countries. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2016; 122(1):6-10.
14. Song W, Song Y, Jo HY. Cancer patients with mucositis assessed during chemo-radiation therapy are at high risk for subsequent development of severe mucositis. Supportive Care in Cancer. 2009; 17(2):203-209.
15. World Health Organization. WHOQOL: Measuring Quality of Life. Geneva: WHO; 1997.
2. Vera-Llonch, M., Oster, G., Hagiwara, M., Sonis, S., & Sen, S. (2006). Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer, 106(2), 329-336.
3. Elting, L. S., Cooksley, C. D., Chambers, M. S., Garden, A. S., & Risk factors, R. M. (2003). Determinants of patient-reported voice and speech changes after adult allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 31(2), 115-122.
4. Dodd, M. J., Dibble, S. L., Miaskowski, C., & MacPhail, L. (2000). A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. Journal of Pain and Symptom Management, 19(5), 331-340.
5. Murphy, B. A., & Epstein, J. B. (2002). Oral mucositis: Review of pathogenesis, diagnosis, prevention, and management. Oncology-Huntington, 16(5 Suppl 7), 17-29.
6. Epstein JB, Schubert MM. Managing pain in mucositis. Seminars in Oncology Nursing. 2004; 20(1):30-37.
7. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology. 1998; 34(1):39-43.
8. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum. 2001; 28(3):465-.
9. Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and
10. Quality of life in patients with advanced cancer. Journal of Pain and Symptom Management. 2007; 33(2):156-165.
11. Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO Clinical Practice Guidelines for the Management of Mositis: Pathophysiology and Management of Mucositis Induced by Cancer Therapy. Supportive Care in Cancer. 2013; 21(9):2233-2245.
12. Mercadante S, Aielli F, Adile C, et al. Pain severity and the antecedents of patients in a palliative care setting. Supportive Care in Cancer. 2015; 23(1):15-19.
13. Elad S, Zadik Y, Garfunkel AA. Oral medicine training in North America: the tale of two countries. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2016; 122(1):6-10.
14. Song W, Song Y, Jo HY. Cancer patients with mucositis assessed during chemo-radiation therapy are at high risk for subsequent development of severe mucositis. Supportive Care in Cancer. 2009; 17(2):203-209.
15. World Health Organization. WHOQOL: Measuring Quality of Life. Geneva: WHO; 1997.